Ligand Enters into OmniAb® Platform License Agreement with Gilead Sciences

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. AKAM
2. COST
3. SPY
4. ZS
5. META
6. NVDA
7. DRI
8. ULS
9. PRME
10. CRL

Go back to Ligand Enters into OmniAb® Platform License Agreement with Gilead Sciences
LIGAND PHARMA (NASDAQ: LGND) Delayed: 295.53 -3.51 (1.17%)
Previous Close $299.04    52 Week High $139.79 
Open $303.17    52 Week Low $82.07 
Day High $303.17    P/E 687.28 
Day Low $293.90    EPS $0.43 
Volume 39,331